Photo Neuromodulation - PhotoPharmics
Overview
PhotoPharmics, Inc is a clinical-stage neurotechnology company based in American Fork, Utah. The company researches how light-based biological signals may influence daily rhythms, non-motor symptoms, and overall experiences in Parkinson’s disease. PhotoPharmics focuses on photo-neuromodulation, studying the interaction of specific wavelengths, timing, and patterns of light with biological timing systems. The investigational device, Celeste™, is currently being evaluated in a home-based, decentralized clinical trial to enhance understanding of these mechanisms. The company aims to expand scientific knowledge of non-motor symptoms in Parkinson’s disease and explore the intersection of biological timing and light-based signals.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- American Fork, Utah
- Type
- Privately Held
- Founded
- 2011
- Followers
- 839
- Specialties
- Parkinson's Disease, Phototherapy, Neuromodulation, photoneuromodulation, Light Therapy, neurological disorders, neurology, Photo Therapy, and Medical Devices
- Locations
- 947 S 500 E American Fork, Utah 84003, US
Funding
Total rounds: 10
Last round: Series B, May 18, 2025
Last round amount: US$ 6.0M